Latest AI and machine learning research in atherosclerosis for healthcare professionals.
UNLABELLED: This study aims to explore the regulatory role of cuproptosis in carotid intimal hyperpl...
The rising prevalence of Type 2 Diabetes (T2D) in Saudi Arabia presents significant healthcare chall...
: Vitamin D deficiency (VDD) is a global health concern associated with metabolic disease and immune...
Diabetic Macular Edema (DME) is a major complication of diabetic retinopathy characterized by fluid ...
Coronary artery disease (CAD) continues to be a leading global cause of cardiovascular related morta...
OBJECTIVES: To develop and evaluate a deep learning model for segmentation of the coronary artery ve...
BACKGROUND: Low-cost/no-cost non-contrast CT calcium scoring (CTCS) exams can provide direct evidenc...
OBJECTIVES: To exploit the capability of super-resolution deep learning reconstruction (SR-DLR) to s...
Insulin resistance (IR) is the core for type 2 diabetes and metabolic syndrome. The homeostasis asse...
OBJECTIVES: Knee subchondral bone marrow lesions (BMLs) are one of the hallmark features of structur...
BACKGROUND AND AIM: Prior investigations of the natural history of abdominal aortic aneurysms (AAAs)...
BACKGROUND: Peripheral arterial disease (PAD) is a common manifestation of atherosclerosis, affectin...
Triptolide, the major component of Chinese herbal medicine Tripterygium wilfordii Hook F, possesses ...
BACKGROUND: Carotid atherosclerotic plaque is the primary cause of cardiovascular and cerebrovascula...
In cardiovascular research, electromagnetic fields generated by Riga plates are utilized to study or...
INTRODUCTION: The accuracy of fenestrations in stent grafts for complex aortic aneurysms and dissect...
How complex phenotypes emerge from intricate gene expression patterns is a fundamental question in b...
BACKGROUND: With the rising diagnostic rate of gallbladder polypoid lesions (GPLs), differentiating ...
Stroke is a leading cause of death and disability globally, particularly in China. Identifying risk ...
BACKGROUND: Established risk models may not be applicable to patients at higher cardiovascular risk ...
Doxorubicin (DOXO) is a primary treatment for breast cancer but can cause cardiotoxicity in over 25%...